Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes

Vasiliki Papadopouloua Service and Laboratory of Hematology, Department of Oncology, Lausanne University Hospital, Lausanne, SwitzerlandCorrespondence[email protected]

Jacqueline Schoumansa Service and Laboratory of Hematology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland

Valentin Basseta Service and Laboratory of Hematology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland

Françoise Sollya Service and Laboratory of Hematology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland

Jérôme Pasquierb Center for Primary Care and Public Health, University of Lausanne, Lausanne, Switzerland

Sabine Bluma Service and Laboratory of Hematology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland

Olivier Spertinia Service and Laboratory of Hematology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland

show all

Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date